1. Home
  2. CLNE vs TNXP Comparison

CLNE vs TNXP Comparison

Compare CLNE & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNE
  • TNXP
  • Stock Information
  • Founded
  • CLNE 2001
  • TNXP 2007
  • Country
  • CLNE United States
  • TNXP United States
  • Employees
  • CLNE N/A
  • TNXP N/A
  • Industry
  • CLNE Natural Gas Distribution
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLNE Utilities
  • TNXP Health Care
  • Exchange
  • CLNE Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • CLNE 448.6M
  • TNXP 365.8M
  • IPO Year
  • CLNE 2007
  • TNXP N/A
  • Fundamental
  • Price
  • CLNE $2.29
  • TNXP $46.49
  • Analyst Decision
  • CLNE Strong Buy
  • TNXP Buy
  • Analyst Count
  • CLNE 3
  • TNXP 1
  • Target Price
  • CLNE $4.33
  • TNXP $70.00
  • AVG Volume (30 Days)
  • CLNE 1.8M
  • TNXP 1.6M
  • Earning Date
  • CLNE 08-07-2025
  • TNXP 08-19-2025
  • Dividend Yield
  • CLNE N/A
  • TNXP N/A
  • EPS Growth
  • CLNE N/A
  • TNXP N/A
  • EPS
  • CLNE N/A
  • TNXP N/A
  • Revenue
  • CLNE $420,579,000.00
  • TNXP $10,041,000.00
  • Revenue This Year
  • CLNE $2.47
  • TNXP $22.87
  • Revenue Next Year
  • CLNE $9.38
  • TNXP $711.66
  • P/E Ratio
  • CLNE N/A
  • TNXP N/A
  • Revenue Growth
  • CLNE 4.08
  • TNXP N/A
  • 52 Week Low
  • CLNE $1.30
  • TNXP $6.76
  • 52 Week High
  • CLNE $3.67
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • CLNE 63.47
  • TNXP 57.37
  • Support Level
  • CLNE $1.94
  • TNXP $35.66
  • Resistance Level
  • CLNE $2.12
  • TNXP $48.50
  • Average True Range (ATR)
  • CLNE 0.12
  • TNXP 3.98
  • MACD
  • CLNE 0.00
  • TNXP -0.05
  • Stochastic Oscillator
  • CLNE 57.38
  • TNXP 73.52

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: